Covered recipient · General Payments record
REBECCA L BURCHFIEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,377.98
- Reported across 151 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $401.78 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $134.21 | 13 |
| Abbott Laboratories | $84.99 | 4 |
| Novo Nordisk AS | $58.31 | 3 |
| Astellas Pharma US Inc | $24.22 | 1 |
| SCILEX PHARMACEUTICALS INC. | $21.31 | 1 |
| Medtronic, Inc. | $17.80 | 1 |
| Janssen Pharmaceuticals, Inc | $16.48 | 1 |
| Renalytix AI, Inc. | $15.42 | 1 |
| Lilly USA, LLC | $14.79 | 1 |
| Amgen Inc. | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.40 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125107686 | CMS |
| Abbott Laboratories | $23.99 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125107680 | CMS |
| Abbott Laboratories | $15.02 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125107682 | CMS |
| Abbott Laboratories | $23.58 | 11/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125107684 | CMS |
| ABBVIE INC. | $7.08 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391367 | CMS |
| ABBVIE INC. | $8.81 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391369 | CMS |
| ABBVIE INC. | $19.34 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391371 | CMS |
| ABBVIE INC. | $14.20 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391373 | CMS |
| ABBVIE INC. | $6.39 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391375 | CMS |
| ABBVIE INC. | $9.60 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391377 | CMS |
| ABBVIE INC. | $10.75 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391379 | CMS |
| ABBVIE INC. | $10.62 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391381 | CMS |
| ABBVIE INC. | $13.21 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391383 | CMS |
| ABBVIE INC. | $4.41 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391385 | CMS |
| ABBVIE INC. | $10.04 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391387 | CMS |
| ABBVIE INC. | $8.93 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391389 | CMS |
| ABBVIE INC. | $10.83 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103391391 | CMS |
| Amgen Inc. | $14.25 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117517109 | CMS |
| Astellas Pharma US Inc | $24.22 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139340696 | CMS |
| Janssen Pharmaceuticals, Inc | $16.48 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078211341 | CMS |
| Lilly USA, LLC | $14.79 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135382301 | CMS |
| Medtronic, Inc. | $17.80 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119358515 | CMS |
| Novo Nordisk Inc | $16.70 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096843117 | CMS |
| Novo Nordisk Inc | $21.63 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096830042 | CMS |
| Novo Nordisk Inc | $19.98 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097420280 | CMS |
| Renalytix AI, Inc. | $15.42 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116758578 | CMS |
| SCILEX PHARMACEUTICALS INC. | $21.31 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136272722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.